GI
GAMMA Investing Portfolio holdings
AUM
$1.58B
1-Year Return
23.44%
This Quarter Return
+12.18%
1 Year Return
+23.44%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$491M
AUM Growth
+$122M
(+33%)
Cap. Flow
+$91.2M
Cap. Flow
% of AUM
18.58%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,414
New
215
Increased
2,072
Reduced
600
Closed
93
Top Buys
| 1 |
Microsoft
MSFT
|
+$4.2M |
| 2 |
NVIDIA
NVDA
|
+$3.59M |
| 3 |
iShares Core Dividend Growth ETF
DGRO
|
+$2.39M |
| 4 |
Amazon
AMZN
|
+$2.33M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.71M |
Top Sells
| 1 |
Kimco Realty
KIM
|
+$158K |
| 2 |
WBB
Westbury Bancorp, Inc.
WBB
|
+$124K |
| 3 |
BHP
BHP
|
+$79K |
| 4 |
Caesars Entertainment
CZR
|
+$55.2K |
| 5 |
Healthcare Realty
HR
|
+$47K |
Sector Composition
| 1 | Technology | 22.4% |
| 2 | Financials | 13% |
| 3 | Healthcare | 9.95% |
| 4 | Consumer Discretionary | 8.47% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Hilton Grand Vacations
HGV
$4.07B
| $2.79K | ﹤0.01% |
59
+11
| +23% | +$519 |
|
2302
Hess Midstream
HESM
$5.21B
| $2.78K | ﹤0.01% |
77
| – | – |
|
|
JBIO
2303
Jade Biosciences, Inc. Common Stock
JBIO
$253M
| $2.78K | ﹤0.01% |
3
+1
| +50% | +$927 |
|
2304
Keros Therapeutics
KROS
$640M
| $2.78K | ﹤0.01% |
42
+5
| +14% | +$331 |
|
|
EFC
2305
Ellington Financial
EFC
$1.35B
| $2.78K | ﹤0.01% |
235
-152
| -39% | -$1.8K |
|
2306
Integra LifeSciences
IART
$1.21B
| $2.77K | ﹤0.01% |
78
+35
| +81% | +$1.24K |
|
2307
Zeta Global
ZETA
$4.94B
| $2.77K | ﹤0.01% |
253
+224
| +772% | +$2.45K |
|
|
FPI
2308
Farmland Partners
FPI
$482M
| $2.76K | ﹤0.01% |
249
-12
| -5% | -$133 |
|
2309
Ginkgo Bioworks
DNA
$618M
| $2.76K | ﹤0.01% |
59
-92
| -61% | -$4.3K |
|
2310
Endava
DAVA
$543M
| $2.74K | ﹤0.01% |
72
-201
| -74% | -$7.65K |
|
2311
FMC
FMC
$4.77B
| $2.74K | ﹤0.01% |
+43
| New | +$2.74K |
|
2312
Biohaven
BHVN
$1.49B
| $2.74K | ﹤0.01% |
50
+24
| +92% | +$1.31K |
|
2313
Elbit Systems
ESLT
$23.4B
| $2.73K | ﹤0.01% |
13
+8
| +160% | +$1.68K |
|
2314
Sally Beauty Holdings
SBH
$1.51B
| $2.72K | ﹤0.01% |
219
+99
| +83% | +$1.23K |
|
2315
F&G Annuities & Life
FG
$4.64B
| $2.72K | ﹤0.01% |
67
| – | – |
|
2316
Crinetics Pharmaceuticals
CRNX
$3.18B
| $2.72K | ﹤0.01% |
58
+16
| +38% | +$749 |
|
2317
Castle Biosciences
CSTL
$660M
| $2.68K | ﹤0.01% |
121
+100
| +476% | +$2.22K |
|
|
ARR
2318
Armour Residential REIT
ARR
$1.72B
| $2.67K | ﹤0.01% |
135
+77
| +133% | +$1.52K |
|
2319
Southern Missouri Bancorp
SMBC
$639M
| $2.67K | ﹤0.01% |
61
| – | – |
|
|
SIX
2320
DELISTED
Six Flags Entertainment Corp.
SIX
| $2.66K | ﹤0.01% |
101
| – | – |
|
|
EDN
2321
Edenor
EDN
$789M
| $2.65K | ﹤0.01% |
150
+142
| +1,775% | +$2.51K |
|
2322
Energizer
ENR
$1.99B
| $2.65K | ﹤0.01% |
90
-153
| -63% | -$4.51K |
|
2323
Concentrix
CNXC
$3.4B
| $2.65K | ﹤0.01% |
40
-16
| -29% | -$1.06K |
|
2324
Protolabs
PRLB
$1.2B
| $2.65K | ﹤0.01% |
74
+40
| +118% | +$1.43K |
|
2325
Relmada Therapeutics
RLMD
$50.5M
| $2.65K | ﹤0.01% |
569
| – | – |
|